Israel develops alternative to dual energy X-ray absorptiometry (DXA) for osteoporosis
This article was originally published in Clinica
Executive Summary
Researchers at Hadasit, the commercial arm of the Hadassah Hospital in Israel, have developed a low-cost test as an alternative to dual energy X-ray absorptiometry (DXA) for diagnosing osteoporosis. Although the cell culture procedure is lengthy (a complete diagnosis takes three weeks), it requires one-tenth of the initial investment of DXA and is thus suitable for poorer countries, says the institution.
You may also be interested in...
Moderna Ready To File Vaccine After Second Impressive Read-Out
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Coronavirus Notebook: UK On Cusp Of First Vaccine Approval, Moderna To File mRNA-1273 in US & EU
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.
Edgewell Finds COVID Bright Side: Wet Ones On Way To Becoming ‘Little Mega-Brand’
Skin hygiene is one of several categories where Edgewell Personal Care has a “right to win" after 18 months of renovations, according to the company’s 20 November Investor Day presentation. The firm has doubled its production capacity and has plans for a “full suite” of product innovation to build on Wet Ones’ 60% growth in fiscal 2020.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: